COMPANY PROFILE

Blue Arbor Technologies

Request full access

Blue Arbor Technologies - The Future of Prosthetic Control

Ann Arbor, United StatesFounded 2023Health Tech & Medtech

Valuation $50–100M Last recorded · 2026

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Blue Arbor Technologies

Blue Arbor Technologies is an Ann Arbor, Michigan-based medical technology company developing neuromuscular interfaces that give people with limb loss natural, intuitive control of prosthetic devices. Building on more than two decades of research at the University of Michigan, the company harnesses volitional motor signals from muscles and nerves so patients can control each finger of an advanced prosthetic hand in real time. In 2026 the company completed a first-in-human procedure of its RESTORE neuromuscular interface system and announced a strategic partnership with Ottobock, which invested $5 million as lead investor in its Series A financing.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2023
Headquarters: Ann Arbor, United States
Employees: 8
Open positions: 1
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech
Technology: Artificial Intelligence
Business model: Manufacturing
Client focus: B2B
Links: Website LinkedIn

Knowledge graph

Founder mafias, market maps, lists and research connected to this company by Dealroom

Market maps in Health Tech & Medtech

Market map Global Metabolic Health startups (Health) Market map Health startups in Quebec Sep 10, 2026

Market map Global Consumer Mental Health companies

Open roles

1 open position

Track hiring at Blue Arbor TechnologiesOpen roles, team growth and hiring by functionBook a demo

Looking for a job? The startup jobs board lists open roles.Startups hiring now →

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
EARLY VC✓Equity / VC	Aug 2026	$0	—	Undisclosed	↗
SERIES A✓Equity / VC	Feb 2026	$10M	$41M	Ottobock	↗

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Blue Arbor Technologies website traffic

Latest recorded traffic for Blue Arbor Technologies is 520 monthly website visits, down 67.5% over the last three months.

Latest monthly visits520 3-month web change-67.5%

Monthly website visitsJan 2026–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
MOModendoUltrathin endomicroscopes for minimally invasive cellular imaging.	Boulder, United States	Operational	6	$500K	—
DEDeepNeuroAI systems for healthcare and computational neuroscience	San Francisco, United States	Operational
MEMedivAIAI-driven continuous monitoring for proactive health management	Doha, Qatar	Operational
WEWellysisWearable ECG monitor with AI-powered arrhythmia detection.	Seoul, South Korea	Operational
AIAi-BrainScienceA medical device manufacturing and sales business	Suita-Shi, Japan	Operational
PMPengfengcheng MedicalA developer of automated vision testing equipment for young children	China	Operational
SUSurgeInnovative fingerprinting of the immune system with AI to holistically improve the perioperative standard-of-care	Paris, France	Operational
VIVision Surgery AI Inc.Artificial Intelligence and Computer Vision applied to Surgery in order to reduce Risk of Failure and reduce the costs	San Francisco, United States	Operational